Ahmed Aribi Selected Research

Ahmed Aribi Research Topics

8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2018
6	Neoplasms (Cancer) 01/2020 - 09/2008
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2022 - 10/2018
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2020
4	Leukemia 01/2022 - 02/2017
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2007
2	Residual Neoplasm 02/2022 - 01/2020
2	Primary Myelofibrosis (Myelosclerosis) 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 06/2013 - 06/2006
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2007 - 01/2007
1	Pathologic Complete Response 01/2022
1	Severe Acute Respiratory Syndrome 11/2021
1	Water Intoxication 10/2021
1	Hemorrhagic Cystitis 10/2021
1	Pulmonary Hypertension 01/2020
1	Invasive Fungal Infections 12/2019
1	Neutropenia 12/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2018
1	Philadelphia Chromosome 02/2017
1	Lymphoma (Lymphomas) 11/2009
1	T-Cell Leukemia (Leukemia, T Cell) 11/2009
1	Infections 11/2009
1	Thrombocytopenia (Thrombopenia) 09/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2008
1	Large Granular Lymphocytic Leukemia 07/2007
1	Acute Promyelocytic Leukemia 04/2007
1	Systemic Mastocytosis 10/2006

6	venetoclaxIBA 01/2021 - 01/2018
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2017
2	blinatumomabIBA 02/2022 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 04/2017
2	Decitabine FDA Link 02/2007 - 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	fludarabineIBA 01/2022
1	VaccinesIBA 11/2021
1	Mesna (Coenzyme M)FDA LinkGeneric 10/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	fms-Like Tyrosine Kinase 3IBA 07/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Busulfan (Busulfex)FDA Link 01/2020
1	cucurbitacin BIBA 06/2013
1	Docetaxel (Taxotere)FDA Link 06/2013
1	TriterpenesIBA 06/2013
1	Pharmaceutical PreparationsIBA 06/2013
1	Gemcitabine FDA Link 06/2013
1	Alemtuzumab (Campath)FDA Link 11/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2009
1	Pentostatin (Nipent)FDA LinkGeneric 11/2009
1	Tyrosine Kinase InhibitorsIBA 09/2008
1	Interleukin-11 (Interleukin 11)IBA 09/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2007
1	Arsenic Trioxide (Trisenox)FDA Link 04/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2007
1	Gemtuzumab (Mylotarg)FDA Link 04/2007
1	Cladribine FDA LinkGeneric 10/2006
1	Interferon-alpha (Interferon Alfa)IBA 10/2006
1	Biomarkers (Surrogate Marker)IBA 06/2006
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2006

15	Therapeutics 02/2022 - 06/2006
10	Cell Transplantation 01/2022 - 10/2018
3	Homologous Transplantation 01/2022 - 12/2017
3	Drug Therapy (Chemotherapy) 01/2020 - 06/2013
2	Lymphatic Irradiation 01/2022 - 04/2017
2	Transplantation 01/2022 - 01/2019
2	Salvage Therapy 01/2021 - 01/2020
1	MDC protocol 01/2020
1	Stem Cell Transplantation 12/2017
1	Hematopoietic Stem Cell Transplantation 04/2017
1	Drug Tapering 09/2008